Skip to main content
. 2022 Mar 24;10(4):761. doi: 10.3390/biomedicines10040761

Figure 3.

Figure 3

Heatmap analysis performed on significant matched spots in benralizumab time points analysis (A) and mepolizumab time points analysis (B). On the right, the line charts show the trend of abundance of the clustered spots.